Why is polio still a concern, also in Europe?

Thea K Fischer^{1

2}, Caroline Klint Johannesen¹, Natasa Berginc³, Jean-Luc Bailly⁴, Kim Benschop^{5

6}, Heli Harvala^{7

8}

Affiliations

¹ Department of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark.
² Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
³ National Laboratory of Health, Environment and Food, National WHO Reference Laboratory for Polio, Ljubljana, Slovenia.
⁴ Université Clermont Auvergne, CNRS, Laboratoire Microorganismes Génome Environnement, France.
⁵ National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
⁶ Centre for Infectious Disease Control (CIb), the Netherlands.
⁷ Microbiology Services, National Health Service (NHS) Blood and Transplant, London, UK.
⁸ Division of Infection and Immunity, University College London, London, UK.

Thea K Fischer et al. Lancet Reg Health Eur. 2024.

. 2024 Jun 25:43:100988.

doi: 10.1016/j.lanepe.2024.100988. eCollection 2024 Aug.

Thea K Fischer^{1

2}, Caroline Klint Johannesen¹, Natasa Berginc³, Jean-Luc Bailly⁴, Kim Benschop^{5

6}, Heli Harvala^{7

8}

¹ Department of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark.
² Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
³ National Laboratory of Health, Environment and Food, National WHO Reference Laboratory for Polio, Ljubljana, Slovenia.
⁴ Université Clermont Auvergne, CNRS, Laboratoire Microorganismes Génome Environnement, France.
⁵ National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
⁶ Centre for Infectious Disease Control (CIb), the Netherlands.
⁷ Microbiology Services, National Health Service (NHS) Blood and Transplant, London, UK.
⁸ Division of Infection and Immunity, University College London, London, UK.

No abstract available

Conflict of interest statement

None of the authors have worked in the poliovaccine producing industry or have stocks in poliovaccine companies.

1. Tan S.Y., Ponstein N. Jonas Salk (1914–1995): a vaccine against polio. Singapore Med J. 2019 Jan;60(1):9–10. - PMC - PubMed
1. Fischer T.K., Simmonds P., Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis. 2022;22(1):e35–e40. - PubMed
1. ECDC Poliomyelitis situation update. 2023. https://www.ecdc.europa.eu/en/publications-data/poliomyelitis-situation-... [cited 2024 May 22]. Available from:
1. AFP/polio data. https://extranet.who.int/polis/public/CaseCount.aspx [cited 2024 Jun 4]. Available from:
1. WHO Poliomyelitis (polio) 2024. https://www.who.int/health-topics/poliomyelitis [cited 2024 May 22]. Available from: